{"nct_id":"NCT06875960","title":"A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2025-08-29","start_date_type":"ESTIMATED","primary_completion_date":"2026-12-01","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12-01","completion_date_type":"ESTIMATED","phases":["PHASE4"],"tickers":["BMY"]}